[
    [
        {
            "time": "",
            "original_text": "贝达药业(300558)：三代EGFR-TKI BPI-D0316临床数据 结果与其他同类产品相似",
            "features": {
                "keywords": [
                    "贝达药业",
                    "EGFR-TKI",
                    "BPI-D0316",
                    "临床数据",
                    "同类产品"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral",
                "product_development": "true",
                "competitive_position": "neutral"
            },
            "scores": {
                "News_content": "贝达药业(300558)：三代EGFR-TKI BPI-D0316临床数据 结果与其他同类产品相似",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]